Clinical Trial Update: A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial in postmenopausal Chinese women with osteoporosis completed; results have been posted for romosozumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2024-12-05